Donna E. Hogge

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes et al. · Journal of Clinical Oncology · 2018 · 990 citations · Full text

Medicine, Oncology, Pharmacology +15

Identification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotype

Daniel T. Starczynowski, Florian Kuchenbauer, Bob Argiropoulos et al. · Nature Medicine · 2009 · 650 citations

Life Sciences, Molecular Biology, Molecular Genetics +12

Differential expression of homeobox genes in functionally distinct CD34+ subpopulations of human bone marrow cells.

Guy Sauvageau, Peter M. Lansdorp, Connie J. Eaves et al. · Proceedings of the National Academy of Sciences · 1994 · 510 citations

Life Sciences, Cell Biology, Developmental Biology +17

Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trial

Jörge E. Cortes, Samer K. Khaled, Giovanni Martinelli et al. · The Lancet Oncology · 2019 · 479 citations

Medicine, Oncology, Pharmacology +11

Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.

Andreas Petzer, Donna E. Hogge, Peter M. Landsdorp et al. · Proceedings of the National Academy of Sciences · 1996 · 380 citations

Life Sciences, Cell Biology, Hematology +15